These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15535308)

  • 1. [Radiation therapy effects in ovarian cancer--review].
    Ito H; Uno T; Kawata T; Isobe K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():560-4. PubMed ID: 15535308
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant 32P in the treatment of ovarian carcinoma.
    Condra KS; Mendenhall WM; Morgan LS; Marcus RB
    Radiat Oncol Investig; 1997; 5(6):300-4. PubMed ID: 9436247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavitary use of radioactive colloidal phosphorus 32 in the treatment of epithelial ovarian cancer.
    Saul HM; Sedlacek TV; Heller PB; Glassburn JR; Riva J; Bertoli R; Maslack M; Lin JK
    J Am Osteopath Assoc; 1996 Dec; 96(12):727-32. PubMed ID: 9111774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum.
    Firat S; Erickson B
    Gynecol Oncol; 2001 Feb; 80(2):213-20. PubMed ID: 11161862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
    Curtin JP; Shapiro F
    Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current aspects of adjuvant therapy of early stage ovarian cancer.
    McGuire WP
    Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian carcinoma: adjuvant treatment with P-32.
    Reddy S; Sutton GP; Stehman FB; Hornback NB; Ehrlich CE
    Radiology; 1987 Oct; 165(1):275-8. PubMed ID: 3628782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant radioactive gold therapy of primary stage I c ovarian cancer].
    Schwarz R; Schumacher A
    Zentralbl Gynakol; 1989; 111(23):1538-41. PubMed ID: 2560301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To P32 or not to P32, that is the question.
    Runowicz CD
    Gynecol Oncol; 1993 Aug; 50(2):139-40. PubMed ID: 8375726
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary cytoreduction in epithelial ovarian cancer.
    Morgan MA; Rubin SC
    Crit Rev Oncol Hematol; 1995 Jan; 18(1):1-8. PubMed ID: 7695822
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioactive phosphorus and external radiation as an adjuvant to surgery for ovarian carcinoma.
    Julian CG; Inalsingh CH; Burnett LS
    Obstet Gynecol; 1978 Aug; 52(2):155-60. PubMed ID: 683654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the role of radiotherapy in ovarian cancer.
    Lanciano R; Reddy S; Corn B; Randall M
    Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of adjuvant radiotherapy in granulosa cell tumors of the ovary.
    Hauspy J; Beiner ME; Harley I; Rosen B; Murphy J; Chapman W; Le LW; Fyles A; Levin W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):770-4. PubMed ID: 20472362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
    Skirnisdottir I; Nordqvist S; Sorbe B
    Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (32)P radioisotope therapy for recurrent pilocytic astrocytoma.
    Narayana A; Bhatia S; Souweidane M; Khakoo Y; Zaider M
    Brachytherapy; 2005; 4(2):171-3. PubMed ID: 15893272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early breast cancer: adjuvant chemotherapy or radiotherapy, or both?
    Arriagada R
    Acta Oncol; 2006; 45(5):514-6. PubMed ID: 16864163
    [No Abstract]   [Full Text] [Related]  

  • 19. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma].
    Krause L; Ritter C; Wachtlin J; Kreusel KM; Höcht S; Foerster MH; Bechrakis NE
    Klin Monbl Augenheilkd; 2008 Jul; 225(7):649-52. PubMed ID: 18642208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.